Last reviewed · How we verify
NCT05771610
SB and Cardiac Function and Structure in IHD
trial testing Activity pattern in CVD in Cardiovascular Diseases in 67 participants. Status unknown.
1 December 2023
Quick facts
| Lead sponsor | University of Bedfordshire |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 67 |
| Start date | 6 March 2023 |
| Primary completion | 1 December 2023 |
| Estimated completion | 31 December 2023 |
Drugs / interventions tested
- Activity pattern in CVD
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Sedentary Behavior — all drugs for Sedentary Behavior →
Sponsor
University of Bedfordshire
Who can join
18 and older, any sex, with Cardiovascular Diseases or Sedentary Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cardiovascular Disease (CVD) is the leading cause of mortality and morbidity globally. Following a myocardial infarction (MI), an individual is at an increased risk of a secondary event (20-50% higher risk post MI), compared to those with no prior CVD. Independent of physical activity levels, high amounts of daily sitting is a risk factor for CVD, of which sitting is typically used as an indicator for sedentary behaviour. Sedentary behaviour is defined as a waking energy expenditure of less than 1.5 METs (metabolic task equivalent) while in a seated, reclined or lying posture. Currently, there is little knowledge regarding the prevalence of sedentary behaviour ischaemic heart disease. The aim of this study is therefore to measure activity levels of an individual following a diagnosis of ischaemic heart disease, alongside its association to cardiac function and cardiovascular risk factors. Sitting patterns and physical activity will be monitored 24 h/day during each condition using an activPAL activity monitor (PAL Technologies, Glasco, Scotland). This will measure changes in posture and level of activity by cadence.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05771610
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other University of Bedfordshire trials
Trials by the same sponsor.
- NCT05193175 — Effects of Breaking up Sitting Time on Cardiometabolic Risk Markers and Cardiac Function Post Myocardial Infarction · NA · unknown
- NCT04645875 — Substituting Sitting With Standing and Walking in Free-living Conditions Improves Daily Glucose Profile in South Asians · NA · completed
- NCT04053686 — An Intervention to Reduce Prolonged Sitting in Police Staff · NA · completed
- NCT03898206 — Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in South Asian Adults · NA · unknown
- NCT03756194 — CARESSES Testing and Evaluation Phases · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05771610 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Bedfordshire
- Last refreshed: 16 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05771610.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing